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Objectives This study sought to assess clinical and angiographic outcomes in a series of 29 patients
who underwent transcatheter closure of coronary artery ﬁstulae (CAF).
Background Transcatheter closure of CAF has become an alternative to surgical closure, but the
reported experience is relatively limited.
Methods Medical records of all patients with CAF who underwent transcatheter closure at the
Mayo Clinic, Rochester, Minnesota, between 1997 and 2010, were reviewed. Patients with other
complex cardiac lesions and those requiring surgery were excluded.
Results Twenty-nine patients with CAF underwent 36 transcatheter closure procedures. The most
were women (55%), and the median age at the time of transcatheter closure was 49 years. Twenty-
three patients had a single CAF. The most common presenting symptom was chest pain (52%).
Thirty devices were deployed antegrade into 1 or more arterial feeders, 3 using an arteriovenous
wire loop and 3 retrograde at the ﬁstulous connection. Successful closure occurred immediately in
all patients with no residual ﬂow in 89% and with trivial ﬂow in 11%. Four complications occurred
including 2 device migrations, 1 coronary spasm, and 1 coronary thrombosis. A follow-up angiogram
was obtained in 18 (62%) patients with a median time to follow-up angiography of 1.5 years. Ten
patients (56%) of the 18 patients with follow-up angiography had no recanalization of embolized
vessel; 4 patients (22%) had trivial recanalization, and 4 patients (22%) had large recanalization. A
repeat closure procedure was performed in all 4 patients of the latter.
Conclusions Transcatheter closure of CAF is feasible and should be considered in carefully selected
patients. Recanalization of the treated coronary ﬁstulae can occur, so follow-up angiography or
other imaging modality should be performed in these patients. (J Am Coll Cardiol Intv 2011;4:
814–21) © 2011 by the American College of Cardiology Foundation
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815Coronary artery fistulae are abnormal connections between
a coronary artery and a cardiac chamber (coronary—
cameral) or major intrathoracic vessel (arteriovenous). Most
coronary fistulae are congenital in nature; however, they can
also be acquired (1,2). Coronary artery fistulas are rare with
a 0.2% to 0.6% incidence in angiographic series and 0.002%
overall incidence in the general population (3,4). Although
first reported by the German anatomist Wilhelm Krause in
1865, the clinical significance of coronary artery fistulae has
not been well understood. Most patients are asymptomatic.
When symptomatic, the most common findings are heart
failure secondary to volume overload resulting from left to
right shunting, ischemia secondary to coronary steal, ar-
rhythmia, fistula rupture or thrombosis, and infective endo-
carditis (5).
Because of these potential complications, some advocate
closure of coronary artery fistulae even in asymptomatic
patients (5). The American College of Cardiology/American
Heart Association (2008) guidelines for the management of
adults with congenital heart disease recommend closure of
all large coronary artery fistulae regardless of symptomology
using transcatheter or surgical techniques. Guidelines call
for closure of small to moderate fistulae only in the presence
of symptoms (including ischemia, arrhythmia, and unex-
plained systolic or diastolic dysfunction). The American Col-
lege of Cardiology/American Heart Association guidelines
do not recommend closure of small, asymptomatic coronary
artery fistulae (6). Surgical closure has been the mainstay of
treatment; however, Reidy et al. (7), in 1983, first reported
transcatheter closure, which has become an alternative
treatment in patients with suitable anatomy. Transcatheter
closure has several theoretical advantages over open heart
surgery, including shorter hospitalization and quicker recov-
ery. A number of transcatheter studies have reported acute
procedural success rates but longitudinal follow-up is lack-
ing. The aim of this study was to evaluate acute and late
clinical and angiographic outcomes in patients treated with
percutaneous transcatheter closure.
Methods
The medical records of 29 adult patients with coronary
artery fistulae who underwent transcatheter closure at the
Mayo Clinic, Rochester, Minnesota, between 1997 and
2010, were retrospectively reviewed. The 29 patients were
largely referred to our catheterization laboratory after diag-
nosis of coronary artery fistulae. Patients were included in
the study if they were symptomatic or had large fistulae.
Patients with small incidentally found fistulae and those
with complex additional cardiac lesions or who required
surgery were excluded. Institutional Review Board approval
was obtained, and only patients who consented for the
procedure and for medical records research were included.
Thirty-six transcatheter closure procedures in the 29 pa-tients were undertaken. All patients underwent cardiac
evaluations including history, physical examination, labora-
tory, and electrocardiogram. A sizable minority of patients
had echocardiography and stress testing before intervention.
Transcatheter closure. Access was obtained with femoral
arterial and venous catheters. Once access was secured, all
patients received an intravenous heparin bolus (60 to 100
U/kg). After obtaining hemodynamic data, the coronary
arteries were engaged selectively using various diagnostic
guides and catheters. Hand injection of contrast allowed
visualization of coronary anatomy, and location of fistulae
including origin and drainage sites. To access the fistula,
guides, microcatheters, and coronary guidewires were used.
Multiple different closure devices were used including Tor-
nado coils (Cook Medical, Bloomington, Indiana), Nester
coils (Cook Medical), Amplatzer ductal occluder (AGA
Medical Corporation, Golden Valley, Minnesota), Am-
platzer Vascular Plug (AGA Medical Corporation), Con-
tour Embolization Particles (Boston Scientific, Natick,
Massachusetts), and iCast covered stent (Atrium Medical,
Hudson, New Hampshire). Devices were selected by the
operator based on the size and other characteristics of the
fistulae. Coils were primarily used in small- to medium-
sized fistulae, whereas the Am-
platzer devices were used to oc-
clude larger fistulas. Details
regarding the devices and their
specific delivery systems have
been reported elsewhere (7–11).
Devices were deployed either via
the femoral artery or femoral
vein, using an arteriovenous wire loop (via femoral artery
and femoral vein or jugular vein) when necessary. Selective
coronary angiography was performed immediately after
device deployment to assess presence of residual flow.
Data analysis. Continuous variables were expressed as me-
ian (interquartile range) and categorical data as percentage.
Follow-up. Medical records and follow-up tests, if available,
including electrocardiograms, echocardiograms, and stress
tests were reviewed. Follow-up angiograms were performed
in selected patients and were reviewed for presence, rate,
and size of fistula recanalization. Subsequent transcatheter
closure was performed if the recanalized fistula was deemed
significant.
Results
The clinical characteristics of the cohort are summarized in
Table 1. Twenty-nine patients with coronary fistulae un-
derwent 36 transcatheter closure procedures. Twenty-three
patients had single fistulas, and 6 had multiple fistulae.
Most patients were women (55%), and the median patient
age at the time of the procedure was 49 (interquartile range:
Abbreviations
and Acronyms
LAD  left anterior
descending artery
PA  pulmonary artery
RCA  right coronary artery19 to 71) years. Of the 29 patients, 27 had symptoms.
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816Although chest pain was the most common presenting
symptom, occurring in 15 patients (52%), dyspnea was also
common and was present in 7 (24%) patients. One patient
presented with fevers and was subsequently found to have
endocarditis. Two patients were asymptomatic but had large
fistulae. A continuous systolic-diastolic murmur was present
in 9 patients (31%); and no murmur was heard in 20 patients.
Fourteen patients (48%) were receiving antiplatelet therapy
before intervention. The most common electrocardiogram
findings were nonspecific ST- and T-wave changes, which
were present in 24% of the patients. Thirteen patients had
echocardiography before the procedure and 9 of those 13 had
Doppler and 2-dimensional evidence of coronary artery fistu-
lae, including chamber (right ventricle or right atrium)
volume overload. Seventeen patients underwent functional
stress testing with either echocardiography or nuclear im-
aging before the procedure. Of those 17 patients, 10 had
documented ischemia on their stress tests corresponding to
the area supplied by the feeding artery.
Coronary artery fistulae origin and drainage site is shown
in Figure 1. Origin from the left anterior descending artery
(LAD) was the most common origin, followed by the right
coronary artery (RCA) and circumflex artery. One patient
had fistulae originating from the aortic arch. The fistulas
drained most commonly into the pulmonary artery, in 19
cases. Of those, 11 came from the LAD, 5 from the RCA,
Table 1. Clinical Characteristics, Imaging Findings, and
Complications of the Cohort (n  29)
Women 16 (55)
Age at catheterization, yrs 49 (19–71)
Single coronary artery ﬁstulae 23 (82)
Recorded symptoms
Chest pain 15 (52)
Dyspnea 7 (24)
Palpitations 4 (14)
Fever 1 (3)
Murmur (continuous diastolic) 9 (31)
Medications
Aspirin 14 (48)
Warfarin 2 (7)
Electrocardiographic ﬁndings
Nonspeciﬁc 7 (24)
Echocardiogram 9 (32)
Stress test 10 (36)
Other cardiac lesions 1 (3)
Interventions 36
Complications
Device migration 2 (7)
Coronary spasm 1 (3)
Thrombosis 1 (3)
Time to follow-up angiogram, yrs 1.5 (0.3–5.0)
Values are n (%) or median (interquartile range).2 from the left circumflex, and 1 from the aortic arch.In the 36 closure procedures performed, coils were placed
in 31 procedures, an Amplatzer ductal occluder in 1 proce-
dure, an Amplatzer vascular plug in 2 procedures, a covered
stent in 1, and Contour embolization particles were used in
1 procedure (Fig. 2). Thirty devices were deployed via an
arterial approach and 3 using an arteriovenous wire loop.
Three devices were delivered transvenously (via the femoral
or jugular vein) (Fig. 3). Immediate post-deployment angiog-
raphy (Fig. 4) documented complete occlusion in 32 (89%)
procedures and trivial residual flow in 4 (11%) procedures.
Four complications (14%) occurred and included coro-
nary spasm in 1 patient that was successfully treated with
intracoronary and sublingual nitroglycerin. Two patients, 1
with circumflex-to–coronary sinus fistulae and 1 with right
coronary artery–to–pulmonary artery fistulae had emboliza-
tion of Tornado coils into the coronary sinus and left lower
lobe branch pulmonary artery. The coils were successfully
removed with a 4-mm snare without sequelae. One patient
Figure 1. Coronary Artery Fistulae Origin and Drainage Sites
Origin from the left anterior descending artery (LAD) was most common,
followed by the right coronary artery (RCA) and circumﬂex (Circ). Fistulas
drained most commonly into the pulmonary artery (PA). CS  coronary
sinus; RA  right atrium; RV  right ventricle; SVC  superior vena cava.
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817with multiple LAD-to-right ventricle fistulae treated with a
covered stent developed chest pain the day after the proce-
dure. Coronary angiography showed complete occlusion of
the LAD due to thrombosis of the covered stent. Throm-
bectomy, coronary angioplasty, and stenting with a bare-
metal stent were performed and the patient subsequently
did well. There were no deaths, strokes, fistulae dissection,
or significant arrhythmias.
Clinical follow-up was available in 19 patients at median
of 1.2 years (range: 1 month to 5 years). Eight of the 19
patients were symptomatic at clinical follow-up. Three
patients were dyspneic, 3 had chest pain, and 2 had
Figure 3. Catheter Approach
Approaches used to deliver devices. Thirty devices were deployed via an
arterial approach (retrograde), 3 via venous approach (antegrade), and
Figure 2. Occlusion Device
The frequency of occlusion devices used to close coronary artery ﬁstulae.
AMP  Amplatzer; Emb  embolization.3 using an arteriovenous wire loop.palpitations secondary to atrial arrhythmias. Follow-up
echocardiography was obtained in 12 patients at median of
5 months (range: 1 month to 7 years) and none had
2-dimensional or Doppler evidence of abnormal flows.
Eight patients underwent nuclear stress testing, but only 2
of those patients had ischemia. Both were later found to
have recanalization of fistulae.
Follow-up angiography. A follow-up angiogram was ob-
ained in 18 (62%) patients at a median of 1.5 years (range:
months to 4.5 years) after the initial procedure. Ten
atients (56%) had no recanalization, 4 patients (22%) had
rivial recanalization, and 4 patients (22%) had significant
ecanalization (Fig. 5). Of the 14 patients with none or trace
ecanalization, 4 had symptoms compared with 3 of the 4
ith large recanalization. All 4 of the patients with large
ecanalization underwent reclosure. Three required recoil-
ng of previously closed fistulas (RCA to pulmonary artery
PA] and LAD to PA). Another patient underwent direct
igation of fistulae during coronary artery bypass grafting for
ymptomatic coronary artery disease. One patient who had
n RCA-to-PA fistula closed 14 months earlier had growth
f a separate LAD-to-PA fistula on follow-up angiogram,
nd it was closed with coils. Examples depicting the types of
evices used to close coronary fistulae in this patient series is
hown in Figures 6, 7, 8, and 9.
iscussion
Percutaneous approaches to closure of coronary artery fis-
tulae are an alternative to traditional surgical closure. We
document acute success and complication rates for this rare
procedure. Although the guidelines recommend closure of
all large fistulae and small to moderate ones in the presence
of symptoms, elective closure of all fistulae even in child-
Figure 4. Residual Flow at Procedure Completion
Angiography taken immediately after device deployment shows complete
occlusion in 32 (89%) procedures and trivial residual ﬂow in 4 (11%)
procedures.hood is advocated by some to prevent future complications
p
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818(12–16). Defining the size of coronary artery fistulae is
controversial and has not been done systematically. Many
definitions have been proposed including calling coronary
artery fistulae “small” if fistula is not larger than twice the
proximate, “medium” if bigger than twice but smaller than
3 the size of proximate, and “large” if bigger (17). The
rognostic significance of clinically silent coronary artery
stulae have been investigated by Sherwood et al. (18). In
Figure 5. Recanalization Rate at Follow-Up Angiogram
The frequency of ﬁstula recanalization noted at follow-up angiography. A
follow-up angiogram was obtained in 18 (62%) patients at a median of
1.5 years (range: 3 months to 4.5 years) after the initial procedure. Ten
patients (56%) had no recanalization, 4 patients (22%) had trivial recanaliza-
tion, and 4 patients (22%) had signiﬁcant recanalization.
Figure 6. LAD-to-RV FistulaeSelective angiography of LAD-to-RV ﬁstulae (A) before and (B) after coiling. Abbrevi31 patients with echocardiographic and catheterization
findings of clinically silent coronary fistulae, at mean
follow-up of 2.6 years, none developed symptoms and 7
(23%) were later found to have spontaneous closure based
on either echocardiogram or angiography.
Before the advent of percutaneous approaches, surgical
closure of coronary fistulae was the only option. The first
successful surgical closure was reported by Biorck et al. (16)
in 1947. Since then, there have been many published series
with up to 56 patients. Overall, mortality is low (1%);
single ligation is common; excision of fistula is rare; and
cardiopulmonary bypass is used in approximately one-half
of the cases (19,20). Reported complications are rare and
include arrhythmias, myocardial infarctions, stroke, and
ST-/T-wave changes on the electrocardiogram. Approxi-
mately a 10% rate of incomplete closure or recurrence of
fistulae is reported in the surgical literature (21). However,
in the Cheung et al. series of 41 patients (21), 21 agreed to
undergo follow-up cardiac catheterization. Among the 21, 4
(19%) had residual or recurrent fistulae. They noted that the
incidence of recurrence was higher in patients who under-
went external plication versus those who had intracardiac
closure.
Transcatheter closure is an emerging alternative in pa-
tients with suitable anatomy and those without other
complex cardiac lesions such as concomitant valvular heart
disease. It was first reported by Reidy et al. (7) in 1983. Over
the years, there have been a series of transcatheter closure
studies in up to 33 patients. Overall, the results have been
comparable to surgery with low morbidity and mortality.
Multiple devices have been used including coils, detachable
balloons, covered stents, vascular plugs, and atrial septal
defect devices. Although, most of the series report excellent
procedural success rate, there is limited information aboutations as in Figure 1.
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819the short- and long-term recanalization rate of transcatheter
treated patients with coronary artery fistulae.
Armsby and colleagues reported short-term findings in
33 patients who underwent transcatheter closure (22).
Follow-up echocardiograms (median: 2.8 years) were ob-
tained in 27 patients. There was no flow in 22 patients and
5 had small residual shunts. None had follow-up angio-
grams. More recently, Zhu et al. (23) reported transcatheter
closure results of 24 patients. All had clinical follow-up
ranging from 3 months to 10 years. No follow-up angio-
gram was obtained. One patient had a still murmur on
examination at 6-month follow-up and subsequent echocar-
diography revealed residual flow. Cardiac catheterization
demonstrated large residual flow, which was closed with
Figure 7. LAD-to-RV Fistulae
Selective angiography of LAD-to-RV ﬁstulae (A) before and (B) after covered s
Figure 8. RCA-to-SVC FistulaeSelective angiography of RCA-to-SVC ﬁstulae (A) before and (B) after Amplatzer duccoils. Review of 45 patients reported in the transcatheter
closure of coronary artery fistulae literature between 1982
and 2002 demonstrated that follow-up (mean: 12 months)
imaging studies were obtained in 33 patients. There were 27
follow-up echocardiograms and only 6 angiograms. Com-
plete closure at follow-up was reported in 91% of cases (22).
In our study, we report short-term findings of one of the
argest transcatheter closure series and the largest number of
atients with follow-up coronary angiography after trans-
atheter closure of coronary fistulae to date. The immediate
losure success rate in our study was equal to or better than
hat has been reported in prior transcatheter closure studies
ith similar patient numbers (22,23) and similar complica-
ion rates. The origin and drainage site of coronary fistulae
eployment. Abbreviations as in Figure 1.tal occluder deployment. Abbreviations as in Figure 1.
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820in our study is similar to those reported in the transcatheter
closure and surgical literature with origin from the left
coronary system and drainage to the pulmonary artery being
the most common. Coils were most commonly used in our
study. All but 6 of the 36 devices were delivered antegrade
(via femoral artery) in our study. In our series, follow-up
angiograms were obtained on 18 patients. Of the 14 patients
without or with trace recanalization, 10 were asymptomatic
at the time of follow-up angiogram. Among the 4 patients
who were found to have significant recanalization flow on
follow-up angiograms, 3 were symptomatic.
The recanalization rate in our study is similar to that of
Cheung et al. (21), who evaluated 41 patients with
surgically closed coronary artery fistulae. Because there is
a paucity of follow-up angiograms in the transcatheter
closure literature, we were unable to compare our recan-
alization rate with any prior transcatheter closure study.
In the surgical literature, there are reports of multiple
other abnormalities noted on follow-up angiograms in-
cluding persistent fistulae and coronary artery dilations
(21). Latson (17) reported 4 patients who underwent
recent follow-up evaluation 4 to 41 years after surgical
closure at his institution. Three of the 4 were found to
have thrombosis of the parent coronary artery. The risk of
parent coronary artery thrombosis after closure either
surgically or percutaneously is unknown as there is little
data with the exception of few case reports (17,24). The
mechanism of thrombus formation after fistulae closure is
unknown, but potential causes include reduction of blood
flow in the aneurysmal artery and trauma. In our series, 1
patient with multiple LAD-to–right ventricle fistulae
treated with a covered stent developed stent thrombosis the
Figure 9. RCA-to-SVC Fistulae
Selective angiography of RCA-to-SVC ﬁstulae (A) before and (B) after Amplatzeday after his procedure. Although a large number of patients a(48%) in our series were on aspirin before catheterization,
whether these patients should be receiving either an anti-
platelet agent or anticoagulant such as warfarin before or
after the procedure is unclear. Certainly, stasis of flow can
occur with closure of long-standing coronary artery fistulae
and consideration should be given to oral anticoagulation.
The duration of antiplatelet or anticoagulant therapy after
the procedure is unclear but it is reasonable to continue at
least 4 weeks and perhaps longer.
Given the presence of recanalization in our series as well
as the other post–fistulae closure abnormalities noted in the
surgical literature, it is important to routinely follow these
patients’ after fistulae closure even if they remain asymp-
tomatic. When compared with other modalities such as
an echocardiogram or computed tomography scan, an-
giography has the advantage of allowing direct device
visualization and sizing of recanalization. Finally, 4
patients in our series had periprocedural complications.
This finding underscores the importance of having expe-
rienced operators perform this procedure in appropriately
selected patients.
Study limitations. Our study has several limitations in-
luding its small size and retrospective nature, which
nherently makes it susceptible to certain biases and
imitation to a single center. Most patients included in
ur study were referred to our institution, thus referral
ias does not allow for an accurate assessment of the
revalence of incidentally found coronary artery fistulae.
he numbers of patients with small fistulae who were not
eferred for evaluation is unknown. Not all patients in the
tudy had clinical or angiographic follow-up, and this is
ular plug. Abbreviations as in Figure 1.n important limitation.
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821Conclusions
Transcatheter closure of CAF is feasible and an effective
alternative therapy in patients with coronary artery fistulae
with suitable anatomy. Procedure-related complications are
not inconsequential; therefore, transcatheter closure of cor-
onary artery fistulae should only be undertaken by experi-
enced operators. A minority of patients treated with percu-
taneous transcatheter closure will experience recanalization.
Routine clinical follow-up in all and imaging surveillance
after closure in symptomatic patients should be considered
after transcatheter coronary artery fistulae closure.
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